Turning employee sentiment into hard operational data

Tern plc

Standard wellbeing programmes rarely solve the problems that matter. They tend to be broad, reactive, and detached from how a business actually runs. Managers see participation figures or survey responses and assume all is well.

That gap is now being addressed by tools built leadership decision-making. Instead of asking employees to rate how they feel, these tools extract meaning from how people actually speak, in comments, conversations and open-ended feedback.

Talking Medicines is one of the companies leading this shift. Its PeopleVoice platform translates employee language into operational insight. If a team is struggling with direction or motivation, it shows up early, before it hits output. It’s quantifiable risk data, broken down by cohort, trend and theme. And that data can be used to act precisely, not generally.

The strongest use cases are emerging in teams with high turnover or shifting targets. Instead of issuing another pulse survey or resilience webinar, leaders can see which roles are losing clarity, where communication is falling apart, or which functions are beginning to disengage.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern Plc announces 90% take-up of Open Offer

Tern Plc has received valid acceptances for 50.9 million Open Offer Shares, representing approximately 90% of the shares available. The fully underwritten offer will raise approximately £509,368 before expenses, with admission of the new shares expected on 24 September 2026.

Talking Medicines moves to capture pharma demand for better patient intelligence

Tighter US pharma advertising rules could increase demand for patient intelligence, supporting the relevance of Talking Medicines’ DrugVoice platform.

Tern portfolio company Talking Medicines launches ‘Intent to Prescribe’ DrugVoice application

Talking Medicines has launched a new DrugVoice application combining its Message Resonance Score™ with near-real-time point-of-care data to help pharmaceutical companies assess links between HCP message alignment and prescribing intent.

Device Authority targets secure digital infrastructure for smart ports

Device Authority's Smart, Green Port Blueprint shows how secure device management can support the wider rollout of connected infrastructure across modern ports.

Talking Medicines highlights strategic signals emerging across the GLP-1 consumer market

GLP-1 consumers are increasingly weighing access, affordability, quality, clinical oversight and treatment support, creating new strategic considerations across the wider life sciences market.

Tern Plc launches £509,368 underwritten Open Offer

Tern Plc has announced an underwritten Open Offer to raise approximately £509,368 through the issue of 56.6 million shares at 0.90p each. Qualifying shareholders may subscribe for one new share for every 16 shares held, with the offer closing on 22 September 2026.

Search